Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice-Reference-Cited by-同舟云学术

Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice

Published:2020-11-01 Issue:11 Volume:27 Page:1141-1151
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Rahadian Arief¹,Fukuda Daiju²,Salim Hotimah Masdan¹,Yagi Shusuke¹,Kusunose Kenya¹,Yamada Hirotsugu¹,Soeki Takeshi¹,Sata Masataka¹

Affiliation:

1. Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences

2. Department of Cardio-Diabetes Medicine, Tokushima University Graduate School of Biomedical Sciences

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/27/11/27_52100/_pdf

Reference41 articles.

1. 1) Collaboration NCDRF. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet, 2016; 387: 1513-1530

2. 2) Shaw JE, Sicree RA and Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract, 2010; 87: 4-14

3. 3) Whiting DR, Guariguata L, Weil C and Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of dia betes for 2011 and 2030. Diabetes Res Clin Pract, 2011; 94: 311-321

4. 4) Zimmet P and Alberti KGMM. Surgery or Medical Therapy for Obese Patients with Type 2 Diabetes? N Engl J Med, 2012; 366: 1635-1636

5. 5) Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G and Gregg EW. Achievement of Goals in U.S. Diabetes Care, 1999–2010. N Engl J Med, 2013; 368: 1613-1624

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Cardiovascular Outcomes: A Review of Literature;Cureus;2024-07-04

2. Canagliflozin protects against hyperglycemia-induced cerebrovascular injury by preventing blood-brain barrier (BBB) disruption via AMPK/Sp1/adenosine A2A receptor;European Journal of Pharmacology;2024-04

3. SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits;Cardiovascular Research;2024-03-08

4. Canagliflozin Alleviates Atherosclerosis Progression through Inflammation, Oxidative Stress, and Autophagy in Western Diet-fed ApoE−/− Mice;Cardiovascular Innovations and Applications;2024

5. It’s Time for New Insights into Renovascular Hypertension at the Molecular Level;Journal of Biosciences and Medicines;2024